Sofia de Oliveira Martins

Suggest Changes
Learn More
This study evaluated the efficacy of injection with enhancement solutions containing sodium lactate (NaLac), potassium lactate (KLac), carrageenan, whey protein concentrate (WPC), yeast extract or(More)
ype 1 pseudohypoaldosteronism (PHA-1) was first described n 1958 by Cheek and Perry.1 It is a rare syndrome of aldoserone unresponsiveness, expressed in two forms: renal HA-1 and systemic PHA-1.2,3(More)